{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:08:15Z","timestamp":1793178495372,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-024-02824-8","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T22:01:17Z","timestamp":1715810477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Oral In-Situ Nanoplatform with Balanced Hydrophobic-Hydrophilic Property for Transport Across Gastrointestinal Mucosa"],"prefix":"10.1208","volume":"25","author":[{"given":"Esha S.","family":"Attar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5701-3107","authenticated-orcid":false,"given":"Padma V.","family":"Devarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"issue":"14","key":"2824_CR1","doi-asserted-by":"publisher","first-page":"13044","DOI":"10.1021\/acsnano.3c02403","volume":"17","author":"SA Ejazi","year":"2023","unstructured":"Ejazi SA, Louisthelmy R, Maisel K. Mechanisms of nanoparticle transport across intestinal tissue: an oral delivery perspective. ACS Nano. 2023;17(14):13044\u201361. https:\/\/doi.org\/10.1021\/acsnano.3c02403.","journal-title":"ACS Nano"},{"issue":"3","key":"2824_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/17425247.2018.1420055","volume":"15","author":"R Mittal","year":"2018","unstructured":"Mittal R, Patel AP, Jhaveri VM, Kay S-IS, Debs LH, Parrish JM, et al. Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders. Expert Opin Drug Deliv. 2018;15(3):301\u201318. https:\/\/doi.org\/10.1080\/17425247.2018.1420055.","journal-title":"Expert Opin Drug Deliv."},{"issue":"1","key":"2824_CR3","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ijpharm.2017.09.040","volume":"532","author":"SS Bachhav","year":"2017","unstructured":"Bachhav SS, Dighe VD, Kotak D, Devarajan PV. Rifampicin Lipid-Polymer hybrid nanoparticles (LIPOMER) for enhanced Peyer\u2019s patch uptake. Int J Pharm. 2017;532(1):612\u201322. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.09.040.","journal-title":"Int J Pharm"},{"issue":"2","key":"2824_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2217\/nnm.09.110","volume":"5","author":"E Roger","year":"2010","unstructured":"Roger E, Lagarce F, Garcion E, Benoit J-P. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine. 2010;5(2):287\u2013306. https:\/\/doi.org\/10.2217\/nnm.09.110.","journal-title":"Nanomedicine"},{"issue":"1","key":"2824_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/138920013804545133","volume":"14","author":"M-A Shahbazi","year":"2013","unstructured":"Shahbazi M-A, Santos HA. Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication. Curr Drug Metab. 2013;14(1):28\u201356. https:\/\/doi.org\/10.2174\/138920013804545133.","journal-title":"Curr Drug Metab."},{"issue":"10","key":"2824_CR6","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1039\/C3CS60436E","volume":"43","author":"R Mo","year":"2014","unstructured":"Mo R, Jiang T, Di J, Tai W, Gu Z. Emerging micro-and nanotechnology based synthetic approaches for insulin delivery. Chem Soc Rev. 2014;43(10):3595\u2013629. https:\/\/doi.org\/10.1039\/C3CS60436E.","journal-title":"Chem Soc Rev"},{"issue":"38","key":"2824_CR7","doi-asserted-by":"publisher","first-page":"25444","DOI":"10.1021\/acsami.6b08183","volume":"8","author":"W Shan","year":"2016","unstructured":"Shan W, Zhu X, Tao W, Cui Y, Liu M, Wu L, et al. Enhanced oral delivery of protein drugs using zwitterion-functionalized nanoparticles to overcome both the diffusion and absorption barriers. ACS Appl Mater Interfaces. 2016;8(38):25444\u201353. https:\/\/doi.org\/10.1021\/acsami.6b08183.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"2824_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","volume":"64","author":"LM Ensign","year":"2012","unstructured":"Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64(6):557\u201370. https:\/\/doi.org\/10.1016\/j.addr.2011.12.009.","journal-title":"Adv Drug Deliv Rev"},{"key":"2824_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","volume":"124","author":"JT Huckaby","year":"2018","unstructured":"Huckaby JT, Lai SK. PEGylation for enhancing nanoparticle diffusion in mucus. Adv Drug Deliv Rev. 2018;124:125\u201339. https:\/\/doi.org\/10.1016\/j.addr.2017.08.010.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2824_CR10","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1038\/s41467-018-05061-3","volume":"9","author":"M Yu","year":"2018","unstructured":"Yu M, Xu L, Tian F, Su Q, Zheng N, Yang Y, et al. Rapid transport of deformation-tuned nanoparticles across biological hydrogels and cellular barriers. Nat Commun. 2018;9(1):2607. https:\/\/doi.org\/10.1038\/s41467-018-05061-3.","journal-title":"Nat Commun"},{"key":"2824_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.addr.2017.10.004","volume":"124","author":"C Menzel","year":"2018","unstructured":"Menzel C, Bernkop-Schn\u00fcrch A. Enzyme decorated drug carriers: targeted swords to cleave and overcome the mucus barrier. Adv Drug Deliv Rev. 2018;124:164\u201374. https:\/\/doi.org\/10.1016\/j.addr.2017.10.004.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2824_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ijpharm.2017.09.018","volume":"532","author":"J Leal","year":"2017","unstructured":"Leal J, Smyth HD, Ghosh D. Physicochemical properties of mucus and their impact on transmucosal drug delivery. Int J Pharm. 2017;532(1):555\u201372. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.09.018.","journal-title":"Int J Pharm"},{"key":"2824_CR13","doi-asserted-by":"publisher","unstructured":"Kirch J. The role of fluid dynamics, microstructure and mucociliary clearance in the micro-and macroscopic barrier properties of pulmonary mucus. 2012. https:\/\/doi.org\/10.22028\/D291-22833.","DOI":"10.22028\/D291-22833"},{"key":"2824_CR14","doi-asserted-by":"publisher","unstructured":"Hagesaether E, Adamczak MI, Hiorth M, Tho I. Characterization of Bioadhesion, Mucin\u2010interactions and Mucosal Permeability of Pharmaceutical Nano\u2010and Microsystems. Charact Pharm Nano Microsyst. 2021:171\u2013205. https:\/\/doi.org\/10.1002\/9781119414018.ch5.","DOI":"10.1002\/9781119414018.ch5"},{"issue":"1","key":"2824_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2018.183","volume":"18","author":"AC Anselmo","year":"2019","unstructured":"Anselmo AC, Gokarn Y, Mitragotri S. Non-invasive delivery strategies for biologics. Nat Rev Drug Discovery. 2019;18(1):19\u201340. https:\/\/doi.org\/10.1038\/nrd.2018.183.","journal-title":"Nat Rev Drug Discovery"},{"key":"2824_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2020.01.006","volume":"320","author":"AS Macedo","year":"2020","unstructured":"Macedo AS, Castro PM, Roque L, Thom\u00e9 NG, Reis CP, Pintado ME, et al. Novel and revisited approaches in nanoparticle systems for buccal drug delivery. J Control Release. 2020;320:125\u201341. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.006.","journal-title":"J Control Release"},{"key":"2824_CR17","doi-asserted-by":"publisher","first-page":"100110","DOI":"10.1016\/j.medidd.2021.100110","volume":"12","author":"C Liu","year":"2021","unstructured":"Liu C, Jiang X, Gan Y, Yu M. Engineering nanoparticles to overcome the mucus barrier for drug delivery: Design, evaluation and state-of-the-art. Medicine in Drug Discovery. 2021;12:100110. https:\/\/doi.org\/10.1016\/j.medidd.2021.100110.","journal-title":"Medicine in Drug Discovery"},{"key":"2824_CR18","doi-asserted-by":"publisher","unstructured":"Yang M, Lai SK, Wang Y-Y, Zhong W, Happe C, Zhang M, et al. Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus. Angewandte Chemie (International ed in English). 2011;50(11):2597. https:\/\/doi.org\/10.1002\/anie.201006849.","DOI":"10.1002\/anie.201006849"},{"issue":"28","key":"2824_CR19","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1002\/adma.201201800","volume":"24","author":"LM Ensign","year":"2012","unstructured":"Ensign LM, Schneider C, Suk JS, Cone R, Hanes J. Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery. Adv Mater. 2012;24(28):3887\u201394. https:\/\/doi.org\/10.1002\/adma.201201800.","journal-title":"Adv Mater"},{"key":"2824_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jcis.2020.08.010","volume":"582","author":"Y Gao","year":"2021","unstructured":"Gao Y, He Y, Zhang H, Zhang Y, Gao T, Wang J-H, et al. Zwitterion-functionalized mesoporous silica nanoparticles for enhancing oral delivery of protein drugs by overcoming multiple gastrointestinal barriers. J Colloid Interface Sci. 2021;582:364\u201375. https:\/\/doi.org\/10.1016\/j.jcis.2020.08.010.","journal-title":"J Colloid Interface Sci"},{"key":"2824_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.addr.2017.07.015","volume":"124","author":"VV Khutoryanskiy","year":"2018","unstructured":"Khutoryanskiy VV. Beyond PEGylation: alternative surface-modification of nanoparticles with mucus-inert biomaterials. Adv Drug Deliv Rev. 2018;124:140\u20139. https:\/\/doi.org\/10.1016\/j.addr.2017.07.015.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"2824_CR22","doi-asserted-by":"publisher","first-page":"e1601556","DOI":"10.1126\/sciadv.1601556","volume":"3","author":"CS Schneider","year":"2017","unstructured":"Schneider CS, Xu Q, Boylan NJ, Chisholm J, Tang BC, Schuster BS, et al. Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation. Sci Adv. 2017;3(4):e1601556. https:\/\/doi.org\/10.1126\/sciadv.1601556.","journal-title":"Sci Adv"},{"key":"2824_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.addr.2017.10.001","volume":"124","author":"L Wu","year":"2018","unstructured":"Wu L, Shan W, Zhang Z, Huang Y. Engineering nanomaterials to overcome the mucosal barrier by modulating surface properties. Adv Drug Deliv Rev. 2018;124:150\u201363. https:\/\/doi.org\/10.1016\/j.addr.2017.10.001.","journal-title":"Adv Drug Deliv Rev"},{"key":"2824_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2017.12.034","volume":"272","author":"X Zhang","year":"2018","unstructured":"Zhang X, Cheng H, Dong W, Zhang M, Liu Q, Wang X, et al. Design and intestinal mucus penetration mechanism of core-shell nanocomplex. J Control Release. 2018;272:29\u201338. https:\/\/doi.org\/10.1016\/j.jconrel.2017.12.034.","journal-title":"J Control Release"},{"issue":"1","key":"2824_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.nano.2016.08.025","volume":"13","author":"L Fang","year":"2017","unstructured":"Fang L, Wang L, Yao Y, Zhang J, Wu X, Li X, et al. Micro-and nano-carrier systems: The non-invasive and painless local administration strategies for disease therapy in mucosal tissues. Nanomedicine. 2017;13(1):153\u201371. https:\/\/doi.org\/10.1016\/j.nano.2016.08.025.","journal-title":"Nanomedicine."},{"issue":"6","key":"2824_CR26","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2217\/nnm.12.129","volume":"8","author":"K Forier","year":"2013","unstructured":"Forier K, Messiaen A-S, Raemdonck K, Deschout H, Rejman J, De Baets F, et al. Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy. Nanomedicine. 2013;8(6):935\u201349. https:\/\/doi.org\/10.2217\/nnm.12.129.","journal-title":"Nanomedicine"},{"key":"2824_CR27","doi-asserted-by":"publisher","first-page":"103162","DOI":"10.1016\/j.jddst.2022.103162","volume":"70","author":"B Valamla","year":"2022","unstructured":"Valamla B, Thakor P, Phuse R, Dalvi M, Kharat P, Kumar A, et al. Engineering drug delivery systems to overcome the vaginal mucosal barrier: Current understanding and research agenda of mucoadhesive formulations of vaginal delivery. J Drug Deliv Sci Technol. 2022;70:103162. https:\/\/doi.org\/10.1016\/j.jddst.2022.103162.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2824_CR28","doi-asserted-by":"publisher","first-page":"132107","DOI":"10.1016\/j.cej.2021.132107","volume":"428","author":"S Hu","year":"2022","unstructured":"Hu S, Yang Z, Wang S, Wang L, He Q, Tang H, et al. Zwitterionic polydopamine modified nanoparticles as an efficient nanoplatform to overcome both the mucus and epithelial barriers. Chem Eng J. 2022;428:132107. https:\/\/doi.org\/10.1016\/j.cej.2021.132107.","journal-title":"Chem Eng J"},{"issue":"1","key":"2824_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/btm2.10112","volume":"4","author":"PS Jahagirdar","year":"2019","unstructured":"Jahagirdar PS, Gupta PK, Kulkarni SP, Devarajan PV. Polymeric curcumin nanoparticles by a facile in situ method for macrophage targeted delivery. Bioeng Transl Med. 2019;4(1):141\u201351. https:\/\/doi.org\/10.1002\/btm2.10112.","journal-title":"Bioeng Transl Med"},{"key":"2824_CR30","doi-asserted-by":"publisher","first-page":"120181","DOI":"10.1016\/j.ijpharm.2020.120181","volume":"595","author":"HA Joshi","year":"2021","unstructured":"Joshi HA, Patwardhan RS, Sharma D, Sandur SK, Devarajan PV. Pre-clinical evaluation of an innovative oral nano-formulation of baicalein for modulation of radiation responses. Int J Pharm. 2021;595:120181. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.120181.","journal-title":"Int J Pharm"},{"issue":"5","key":"2824_CR31","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1021\/acsami.8b18107","volume":"11","author":"B Poinard","year":"2019","unstructured":"Poinard B, Kamaluddin S, Tan AQQ, Neoh KG, Kah JCY. Polydopamine coating enhances mucopenetration and cell uptake of nanoparticles. ACS Appl Mater Interfaces. 2019;11(5):4777\u201389. https:\/\/doi.org\/10.1021\/acsami.8b18107.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2824_CR32","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ejpb.2015.01.005","volume":"96","author":"J Grie\u00dfinger","year":"2015","unstructured":"Grie\u00dfinger J, D\u00fcnnhaupt S, Cattoz B, Griffiths P, Oh S, Ig\u00f3mez SB, et al. Methods to determine the interactions of micro-and nanoparticles with mucus. Eur J Pharm Biopharm. 2015;96:464\u201376. https:\/\/doi.org\/10.1016\/j.ejpb.2015.01.005.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"2824_CR33","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/s41467-021-21989-5","volume":"12","author":"S Hu","year":"2021","unstructured":"Hu S, Pei X, Duan L, Zhu Z, Liu Y, Chen J, et al. A mussel-inspired film for adhesion to wet buccal tissue and efficient buccal drug delivery. Nat Commun. 2021;12(1):1689. https:\/\/doi.org\/10.1038\/s41467-021-21989-5.","journal-title":"Nat Commun"},{"issue":"4","key":"2824_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.17756\/jfcn.2017-046","volume":"3","author":"J Westerhout","year":"2017","unstructured":"Westerhout J, Bellmann S, van Ee R, Havenaar R, Leeman W, Steeg E, et al. Prediction of oral absorption of nanoparticles from biorelevant matrices using a combination of physiologically relevant in vitro and ex vivo models. J Food Chem Nanotechnol. 2017;3(4):111\u20139. https:\/\/doi.org\/10.17756\/jfcn.2017-046.","journal-title":"J Food Chem Nanotechnol."},{"key":"2824_CR35","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1023\/A:1019854327540","volume":"19","author":"I Behrens","year":"2002","unstructured":"Behrens I, Pena AIV, Alonso MJ, Kissel T. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm Res. 2002;19:1185\u201393. https:\/\/doi.org\/10.1023\/A:1019854327540.","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"2824_CR36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijpharm.2015.04.073","volume":"489","author":"AB Jindal","year":"2015","unstructured":"Jindal AB, Devarajan PV. Asymmetric lipid\u2013polymer particles (LIPOMER) by modified nanoprecipitation: role of non-solvent composition. Int J Pharm. 2015;489(1\u20132):246\u201351. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.04.073.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"2824_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijpharm.2012.02.042","volume":"429","author":"SV Kapse","year":"2012","unstructured":"Kapse SV, Gaikwad RV, Samad A, Devarajan PV. Self nanoprecipitating preconcentrate of tamoxifen citrate for enhanced bioavailability. Int J Pharm. 2012;429(1\u20132):104\u201312. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.02.042.","journal-title":"Int J Pharm"},{"key":"2824_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120511","volume":"600","author":"R John","year":"2021","unstructured":"John R, Dalal B, Shankarkumar A, Devarajan PV. Innovative betulin nanosuspension exhibits enhanced anticancer activity in a triple negative breast cancer cell line and Zebrafish angiogenesis model. Int J Pharm. 2021;600: 120511. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120511.","journal-title":"Int J Pharm"},{"key":"2824_CR39","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jconrel.2022.07.030","volume":"349","author":"PA Todke","year":"2022","unstructured":"Todke PA, Devarajan PV. In-silico approach as a tool for selection of excipients for safer amphotericin B nanoformulations. J Control Release. 2022;349:756\u201364. https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.030.","journal-title":"J Control Release"},{"key":"2824_CR40","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.carbpol.2015.10.021","volume":"136","author":"AA D'Souza","year":"2016","unstructured":"D\u2019Souza AA, Devarajan PV. Bioenhanced oral curcumin nanoparticles: role of carbohydrates. Carbohyd Polym. 2016;136:1251\u20138. https:\/\/doi.org\/10.1016\/j.carbpol.2015.10.021.","journal-title":"Carbohyd Polym"},{"issue":"2","key":"2824_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.aca.2007.07.011","volume":"597","author":"SC Ferreira","year":"2007","unstructured":"Ferreira SC, Bruns R, Ferreira HS, Matos GD, David J, Brand\u00e3o G, et al. Box-Behnken design: An alternative for the optimization of analytical methods. Anal Chim Acta. 2007;597(2):179\u201386. https:\/\/doi.org\/10.1016\/j.aca.2007.07.011.","journal-title":"Anal Chim Acta"},{"key":"2824_CR42","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.colsurfb.2014.07.037","volume":"122","author":"A Homayouni","year":"2014","unstructured":"Homayouni A, Sadeghi F, Varshosaz J, Garekani HA, Nokhodchi A. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques. Colloids Surf B. 2014;122:591\u2013600. https:\/\/doi.org\/10.1016\/j.colsurfb.2014.07.037.","journal-title":"Colloids Surf B"},{"issue":"12","key":"2824_CR43","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1002\/chem.200903335","volume":"16","author":"CR Crick","year":"2010","unstructured":"Crick CR, Parkin IP. Preparation and characterisation of super-hydrophobic surfaces. Chem Eur J. 2010;16(12):3568\u201388. https:\/\/doi.org\/10.1002\/chem.200903335.","journal-title":"Chem Eur J."},{"issue":"4","key":"2824_CR44","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1021\/la010444o","volume":"18","author":"A Azioune","year":"2002","unstructured":"Azioune A, Chehimi MM, Miksa B, Basinska T, Slomkowski S. Hydrophobic protein\u2212 polypyrrole interactions: The role of van der Waals and Lewis acid\u2212 base forces as determined by contact angle measurements. Langmuir. 2002;18(4):1150\u20136. https:\/\/doi.org\/10.1021\/la010444o.","journal-title":"Langmuir"},{"key":"2824_CR45","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.addr.2017.12.006","volume":"124","author":"PI Chater","year":"2018","unstructured":"Chater PI, Wilcox MD, Pearson JP. Efficacy and safety concerns over the use of mucus modulating agents for drug delivery using nanoscale systems. Adv Drug Deliv Rev. 2018;124:184\u201392. https:\/\/doi.org\/10.1016\/j.addr.2017.12.006.","journal-title":"Adv Drug Deliv Rev"},{"key":"2824_CR46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.addr.2018.01.001","volume":"124","author":"CT Nordg\u00e5rd","year":"2018","unstructured":"Nordg\u00e5rd CT, Draget KI. Co association of mucus modulating agents and nanoparticles for mucosal drug delivery. Adv Drug Deliv Rev. 2018;124:175\u201383. https:\/\/doi.org\/10.1016\/j.addr.2018.01.001.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"2824_CR47","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1021\/la702680x","volume":"24","author":"O Svensson","year":"2008","unstructured":"Svensson O, Thuresson K, Arnebrant T. Interactions between drug delivery particles and mucin in solution and at interfaces. Langmuir. 2008;24(6):2573\u20139. https:\/\/doi.org\/10.1021\/la702680x.","journal-title":"Langmuir"},{"issue":"11","key":"2824_CR48","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.addr.2005.07.008","volume":"57","author":"H Takeuchi","year":"2005","unstructured":"Takeuchi H, Thongborisute J, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Deliv Rev. 2005;57(11):1583\u201394. https:\/\/doi.org\/10.1016\/j.addr.2005.07.008.","journal-title":"Adv Drug Deliv Rev"},{"key":"2824_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ejpb.2014.12.024","volume":"97","author":"IP de Sousa","year":"2015","unstructured":"de Sousa IP, Steiner C, Schmutzler M, Wilcox MD, Veldhuis GJ, Pearson JP, et al. Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles. Eur J Pharm Biopharm. 2015;97:273\u20139. https:\/\/doi.org\/10.1016\/j.ejpb.2014.12.024.","journal-title":"Eur J Pharm Biopharm"},{"key":"2824_CR50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ejpb.2015.05.004","volume":"97","author":"PC Griffiths","year":"2015","unstructured":"Griffiths PC, Cattoz B, Ibrahim MS, Anuonye JC. Probing the interaction of nanoparticles with mucin for drug delivery applications using dynamic light scattering. Eur J Pharm Biopharm. 2015;97:218\u201322. https:\/\/doi.org\/10.1016\/j.ejpb.2015.05.004.","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"2824_CR51","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1016\/j.apsb.2022.10.020","volume":"13","author":"Y Ren","year":"2023","unstructured":"Ren Y, Wu W, Zhang X. The feasibility of oral targeted drug delivery: Gut immune to particulates? Acta Pharmaceutica Sinica B. 2023;13(6):2544\u201358. https:\/\/doi.org\/10.1016\/j.apsb.2022.10.020.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"2824_CR52","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jconrel.2021.04.026","volume":"334","author":"AM Dos Santos","year":"2021","unstructured":"Dos Santos AM, Carvalho SG, Meneguin AB, S\u00e1bio RM, Gremi\u00e3o MPD, Chorilli M. Oral delivery of micro\/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives. J Control Release. 2021;334:353\u201366. https:\/\/doi.org\/10.1016\/j.jconrel.2021.04.026.","journal-title":"J Control Release"},{"issue":"1","key":"2824_CR53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1166\/jnn.2014.9015","volume":"14","author":"E Froehlich","year":"2014","unstructured":"Froehlich E, Roblegg E. Mucus as barrier for drug delivery by nanoparticles. J Nanosci Nanotechnol. 2014;14(1):126\u201336. https:\/\/doi.org\/10.1166\/jnn.2014.9015.","journal-title":"J Nanosci Nanotechnol"},{"issue":"3","key":"2824_CR54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/smll.201201789","volume":"9","author":"BJ Teubl","year":"2013","unstructured":"Teubl BJ, Meindl C, Eitzlmayr A, Zimmer A, Fr\u00f6hlich E, Roblegg E. In-vitro permeability of neutral polystyrene particles via buccal mucosa. Small. 2013;9(3):457\u201366. https:\/\/doi.org\/10.1002\/smll.201201789.","journal-title":"Small"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02824-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-024-02824-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02824-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T16:12:44Z","timestamp":1725379964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-024-02824-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":54,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["2824"],"URL":"https:\/\/doi.org\/10.1208\/s12249-024-02824-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"assertion":[{"value":"22 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"113"}}